Get the Stockscreener App
0.9254
7.46%
-0.0746
Exascale Labs Holdings Inc. Class A Common Stock Stock (XLAB) Forecast
The Exascale Labs Holdings Inc. Class A Common Stock (XLAB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.0772, representing a +16.40% increase from the current price of $0.9254. The highest analyst price target is $2.0921, and the lowest is $0.0623.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month XLAB Price Target
Average 9.3305
(+908.27% Upside)
Is Exascale Labs Holdings Inc. Class A Common Stock (XLAB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 14.65 | Buy |
| STOCH(9,6) | 4.0045 | Buy |
| STOCHRSI(14) | 4.6002 | Buy |
| MACD(12,26) | -0.9418 | Sell |
| ADX(14) | 47.78 | Sell |
| William %R | -98.83 | Buy |
| CCI(14) | -45.73 | Neutral |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.2124
Sell
|
1.3023
Sell
|
| MA20 |
1.9345
Sell
|
1.9547
Sell
|
| MA50 |
1.7725
Sell
|
0.00
Buy
|
| MA100 |
0.8862
Buy
|
0.00
Buy
|
| MA200 |
0.4431
Buy
|
0.00
Buy
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, XLAB could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 7 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on XLAB, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 14.65 indicates that XLAB is oversold. This indicates that XLAB price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 4.0045 indicates that XLAB is oversold. This indicates that XLAB price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.6002 indicates that XLAB is oversold. This suggests that XLAB price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 47.78 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -45.73 indicates that XLAB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term XLAB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Exascale Labs Holdings Inc. Class A Common Stock financial reports and earnings history, Exascale Labs Holdings Inc. Class A Common Stock (XLAB) stock could reach $68.47 by 2030, $287.63 by 2040 and $467.40 by 2050. See the projected annual prices until 2050 of the Exascale Labs Holdings Inc. Class A Common Stock stock below:
- Exascale Labs Holdings Inc. Class A Common Stock (XLAB) is expected to reach an average price of $150.64 in 2035, with a high prediction of $178.05 and a low estimate of $46.59. This indicates an $16,179% rise from the last recorded price of $0.9254.
- Exascale Labs Holdings Inc. Class A Common Stock (XLAB) stock is projected to chart a bullish course in 2040, with an average price target of $218.64, representing an $23,527% surge from its current level. The forecast ranges from a conservative $75.30 to a sky-high $287.63.
- Our analysts predict Exascale Labs Holdings Inc. Class A Common Stock (XLAB) to jump 28,965% by 2045, soaring from $269.13 to an average price of $268.97, potentially reaching $397.21. While $269.13 is the low estimate, the potential upside is significant.
- Exascale Labs Holdings Inc. Class A Common Stock (XLAB) stock is expected to climb by 2050, reaching an average of $300.95, a $32,421% jump from its current level. However, a wide range of estimates exists, with high and low targets of $467.40 and $301.03, respectively, highlighting the market's uncertainty.
Exascale Labs Holdings Inc. Class A Common Stock Stock (XLAB) Year by Year Forecast
Exascale Labs Holdings Inc. Class A Common Stock Stock (XLAB) Price Forecast for 2026
The predicted value for Exascale Labs Holdings Inc. Class A Common Stock (XLAB) in 2026 is set at an average of $3.7261. Estimates vary from a peak of $7.39 to a trough of $0.0623, indicating an +302.65% surge from the present price of $0.9254.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.2911 | $0.0623 | $2.0921 | -68.54% |
| December, 2026 | $3.2892 | $0.2044 | $1.0392 | +255.44% |
Exascale Labs Holdings Inc. Class A Common Stock Stock (XLAB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Exascale Labs Holdings Inc. Class A Common Stock (XLAB) is $11.89, with a high forecast of $22.47 and a low forecast of $1.3087. This indicates an +1,185% increase from the last price of $0.9254.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.7346 | $2.5457 | $3.1226 | +195.50% |
| February, 2027 | $1.926 | $1.9649 | $1.9084 | +108.13% |
| March, 2027 | $5.7236 | $1.3087 | $6.9917 | +518.50% |
| April, 2027 | $3.9866 | $4.0766 | $4.6468 | +330.80% |
| May, 2027 | $9.7038 | $2.4131 | $10.86 | +948.60% |
| June, 2027 | $6.7145 | $6.8065 | $7.4791 | +625.57% |
| July, 2027 | $15.93 | $3.5175 | $13.68 | +1,622% |
| August, 2027 | $10.00 | $10.08 | $14.73 | +980.99% |
| September, 2027 | $4.5965 | $4.6219 | $8.2056 | +396.70% |
| October, 2027 | $15.26 | $15.26 | $18.60 | +1,549% |
| November, 2027 | $7.7258 | $7.7647 | $13.14 | +734.86% |
| December, 2027 | $20.27 | $5.7262 | $22.47 | +2,091% |
Exascale Labs Holdings Inc. Class A Common Stock Stock (XLAB) Price Forecast for 2028
In 2028, Exascale Labs Holdings Inc. Class A Common Stock (XLAB) is projected to reach an average price of $25.01, with a high projection of $43.19 and a low estimate of $6.8306. This indicates an +2,602% rise from the last price of $0.9254.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $11.17 | $11.26 | $16.98 | +1,107% |
| February, 2028 | $26.77 | $6.8306 | $26.34 | +2,793% |
| March, 2028 | $17.46 | $17.54 | $23.21 | +1,787% |
| April, 2028 | $7.9096 | $7.935 | $14.63 | +754.72% |
| May, 2028 | $22.56 | $22.72 | $30.54 | +2,338% |
| June, 2028 | $12.08 | $12.11 | $19.32 | +1,205% |
| July, 2028 | $27.97 | $9.0394 | $34.76 | +2,922% |
| August, 2028 | $16.56 | $16.65 | $24.47 | +1,689% |
| September, 2028 | $38.38 | $10.14 | $38.97 | +4,047% |
| October, 2028 | $21.70 | $21.79 | $33.78 | +2,245% |
| November, 2028 | $45.44 | $11.25 | $43.19 | +4,810% |
| December, 2028 | $31.06 | $31.22 | $41.81 | +3,256% |
Exascale Labs Holdings Inc. Class A Common Stock Stock (XLAB) Price Forecast for 2029
The 2029 price forecast for Exascale Labs Holdings Inc. Class A Common Stock Stock (XLAB) is $38.31 on average, with a high prediction of $64.26 and a low estimate of $12.35. This represents an +4,039% increase from the previous price of $0.9254.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $12.33 | $12.35 | $26.78 | +1,232% |
| February, 2029 | $37.50 | $37.50 | $47.40 | +3,953% |
| March, 2029 | $21.94 | $22.03 | $32.97 | +2,271% |
| April, 2029 | $44.94 | $13.46 | $51.61 | +4,756% |
| May, 2029 | $28.13 | $28.22 | $39.22 | +2,939% |
| June, 2029 | $58.08 | $14.56 | $55.83 | +6,176% |
| July, 2029 | $34.87 | $34.95 | $53.42 | +3,668% |
| August, 2029 | $15.64 | $15.67 | $29.62 | +1,590% |
| September, 2029 | $47.04 | $47.04 | $60.04 | +4,983% |
| October, 2029 | $22.23 | $22.26 | $41.47 | +2,302% |
| November, 2029 | $55.51 | $16.77 | $64.26 | +5,898% |
| December, 2029 | $29.12 | $29.21 | $48.75 | +3,047% |
Exascale Labs Holdings Inc. Class A Common Stock Stock (XLAB) Price Forecast for 2030
Exascale Labs Holdings Inc. Class A Common Stock Stock (XLAB) is expected to reach an average price of $51.60 in 2030, with a high forecast of $85.33 and a low forecast of $17.87. This signifies an +5,476% surge from the last price of $0.9254.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $65.46 | $17.87 | $68.47 | +6,974% |
| February, 2030 | $42.33 | $42.41 | $58.44 | +4,474% |
| March, 2030 | $18.95 | $18.98 | $36.04 | +1,948% |
| April, 2030 | $50.88 | $51.04 | $72.69 | +5,399% |
| May, 2030 | $26.58 | $26.61 | $44.18 | +2,772% |
| June, 2030 | $66.08 | $20.08 | $76.90 | +7,041% |
| July, 2030 | $34.51 | $34.60 | $58.29 | +3,629% |
| August, 2030 | $77.07 | $21.19 | $81.12 | +8,228% |
| September, 2030 | $43.11 | $43.21 | $69.01 | +4,559% |
| October, 2030 | $87.58 | $22.29 | $85.33 | +9,364% |
| November, 2030 | $59.38 | $59.54 | $80.50 | +6,317% |
| December, 2030 | $23.37 | $23.40 | $51.64 | +2,425% |
1.33%
7.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):